Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when SOLV files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSolventum appoints Neil Zieselman as Chief Accounting Officer, succeeding retiring Mary Wilcox
Filed July 20, 2026 · Period ending July 16, 2026 · ~1 min read
Key Changes
-
medium
Neil Zieselman, 50, will become SVP, Controller and Chief Accounting Officer on August 10, 2026, replacing retiring Mary Wilcox. He brings public company accounting experience from Surgery Partners (SVP Corporate Finance and Controller since 2022) and Stryker Corporation.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
medium
Zieselman previously served as Vice President and Chief Accounting Officer at Covanta Holding Corporation and began his career as an auditor at PricewaterhouseCoopers. He is a licensed CPA and will serve as Principal Accounting Officer for SEC reporting.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
low
Compensation includes base salary with 50% target bonus, $500,000 annual long-term incentive target, $130,000 sign-on bonus, and $600,000 in restricted stock units vesting equally over three years.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
Summary
Solventum announced a planned succession in its Chief Accounting Officer role, with Neil Zieselman joining August 10, 2026 to replace retiring Mary Wilcox.
Zieselman brings relevant public company experience from his current role as SVP Corporate Finance and Controller at Surgery Partners since 2022, and prior senior finance positions at Stryker Corporation and Covanta Holding Corporation, where he served as Vice President and Chief Accounting Officer. He is a licensed CPA who started his career at PricewaterhouseCoopers.
This is a routine executive transition for a key financial reporting role. Zieselman's background in public company accounting and SEC reporting at healthcare and medical device companies aligns well with Solventum's needs. The planned nature of the succession and the incoming executive's qualifications suggest continuity in financial reporting and controls. His compensation package is standard for a senior finance executive at a public company of Solventum's size.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On July 16, 2026, the Board of Directors of Solventum Corporation (the “Company”) appointed Neil Zieselman to serve as Senior Vice President, Controller and Chief Accounting Officer of the Company, effective as of August 10, 2026. Mr. Zieselman is replacing Mary Wilcox in this role in connection with her previously announced retirement and will report directly to Wayde McMillan, the Company’s Chief Financial Officer. Mr. Zieselman will function as the Company’s Principal Accounting Officer for Securities and Exchange Commission (“SEC”) reporting purposes.
Neil Zieselman, age 50, will become Solventum's new Chief Accounting Officer on August 10, 2026, succeeding Mary Wilcox who is retiring. He will serve as the company's Principal Accounting Officer for SEC reporting purposes and report to CFO Wayde McMillan. This is a planned succession for a key financial reporting role.
Added in current filing · verify on EDGAR →
Mr. Zieselman, age 50, joins the Company from Surgery Partners, Inc., where he has served as its Senior Vice President, Corporate Finance and Controller since May 2022. Prior to Surgery Partners, Inc., Mr. Zieselman served Stryker Corporation as its Vice President, Finance Operations from April 2021 to May 2022, Senior Director, Finance Transformation from August 2019 to April 2021 and Senior Director, Finance and Group Controller, Orthopaedics Group from January 2017 to August 2019. Prior to joining Stryker Corporation, Mr. Zieselman held accounting and finance leadership roles at Covanta Holding Corporation, including Vice President and Chief Accounting Officer, Cendant Corporation and Avaya Inc. Mr. Zieselman began his career as an auditor with PricewaterhouseCoopers LLP.
Zieselman brings extensive public company accounting experience, most recently as SVP Corporate Finance and Controller at Surgery Partners since May 2022. He previously held senior finance roles at Stryker Corporation and served as Vice President and Chief Accounting Officer at Covanta Holding Corporation. He is a licensed CPA who started his career at PricewaterhouseCoopers.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 21, 2026 · How we verify